Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
Clinical trial NCT04588129 · COMPLETED
Trial details
- NCT number
- NCT04588129
- Sponsor
- LB Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2021-09-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.